These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 27910117)

  • 21. The effects of excluding patients from the analysis in randomised controlled trials: meta-epidemiological study.
    Nüesch E; Trelle S; Reichenbach S; Rutjes AW; Bürgi E; Scherer M; Altman DG; Jüni P
    BMJ; 2009 Sep; 339():b3244. PubMed ID: 19736281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sample size calculation in three-level cluster randomized trials using generalized estimating equation models.
    Liu J; Colditz GA
    Stat Med; 2020 Oct; 39(24):3347-3372. PubMed ID: 32720717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Meta-analysis of ratios of sample variances.
    Prendergast LA; Staudte RG
    Stat Med; 2016 May; 35(11):1780-99. PubMed ID: 27062644
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subgroup analyses in randomised controlled trials: quantifying the risks of false-positives and false-negatives.
    Brookes ST; Whitley E; Peters TJ; Mulheran PA; Egger M; Davey Smith G
    Health Technol Assess; 2001; 5(33):1-56. PubMed ID: 11701102
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heterogeneity and statistical significance in meta-analysis: an empirical study of 125 meta-analyses.
    Engels EA; Schmid CH; Terrin N; Olkin I; Lau J
    Stat Med; 2000 Jul; 19(13):1707-28. PubMed ID: 10861773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Meta-analysis of aggregate data on medical events.
    Holzhauer B
    Stat Med; 2017 Feb; 36(5):723-737. PubMed ID: 27859465
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Meta-analyses involving cluster randomization trials: a review of published literature in health care.
    Laopaiboon M
    Stat Methods Med Res; 2003 Dec; 12(6):515-30. PubMed ID: 14653354
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of covariance with pre-treatment measurements in randomized trials under the cases that covariances and post-treatment variances differ between groups.
    Funatogawa T; Funatogawa I; Shyr Y
    Biom J; 2011 May; 53(3):512-24. PubMed ID: 22223254
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of reported study design characteristics on intervention effect estimates from randomised controlled trials: combined analysis of meta-epidemiological studies.
    Savović J; Jones H; Altman D; Harris R; Jűni P; Pildal J; Als-Nielsen B; Balk E; Gluud C; Gluud L; Ioannidis J; Schulz K; Beynon R; Welton N; Wood L; Moher D; Deeks J; Sterne J
    Health Technol Assess; 2012 Sep; 16(35):1-82. PubMed ID: 22989478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Measures of between-cluster variability in cluster randomized trials with binary outcomes.
    Thomson A; Hayes R; Cousens S
    Stat Med; 2009 May; 28(12):1739-51. PubMed ID: 19378266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selegiline for Alzheimer's disease.
    Birks J; Flicker L
    Cochrane Database Syst Rev; 2003; (1):CD000442. PubMed ID: 12535396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of non-uniform correlation structure on sample size and power in multiple-period cluster randomised trials.
    Kasza J; Hemming K; Hooper R; Matthews J; Forbes AB
    Stat Methods Med Res; 2019 Mar; 28(3):703-716. PubMed ID: 29027505
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Statistical methodology for estimating the mean difference in a meta-analysis without study-specific variance information.
    Sangnawakij P; Böhning D; Adams S; Stanton M; Holling H
    Stat Med; 2017 Apr; 36(9):1395-1413. PubMed ID: 28168731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A critical review of methods for the assessment of patient-level interactions in individual participant data meta-analysis of randomized trials, and guidance for practitioners.
    Fisher DJ; Copas AJ; Tierney JF; Parmar MK
    J Clin Epidemiol; 2011 Sep; 64(9):949-67. PubMed ID: 21411280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Random effects meta-analysis: Coverage performance of 95% confidence and prediction intervals following REML estimation.
    Partlett C; Riley RD
    Stat Med; 2017 Jan; 36(2):301-317. PubMed ID: 27714841
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Indirect comparisons of competing interventions.
    Glenny AM; Altman DG; Song F; Sakarovitch C; Deeks JJ; D'Amico R; Bradburn M; Eastwood AJ;
    Health Technol Assess; 2005 Jul; 9(26):1-134, iii-iv. PubMed ID: 16014203
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Empirical evidence about inconsistency among studies in a pair-wise meta-analysis.
    Rhodes KM; Turner RM; Higgins JP
    Res Synth Methods; 2016 Dec; 7(4):346-370. PubMed ID: 26679486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of the bootstrap in analysing cost data from cluster randomised trials: some simulation results.
    Flynn TN; Peters TJ
    BMC Health Serv Res; 2004 Nov; 4(1):33. PubMed ID: 15550169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of nuisance parameters in pediatric versus adult randomized trials: a meta-epidemiologic empirical evaluation.
    Vandermeer B; van der Tweel I; Jansen-van der Weide MC; Weinreich SS; Contopoulos-Ioannidis DG; Bassler D; Fernandes RM; Askie L; Saloojee H; Baiardi P; Ellenberg SS; van der Lee JH
    BMC Med Res Methodol; 2018 Jan; 18(1):7. PubMed ID: 29321002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of covariance with pre-treatment measurements in randomized trials: comparison of equal and unequal slopes.
    Funatogawa I; Funatogawa T
    Biom J; 2011 Sep; 53(5):810-21. PubMed ID: 21887795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.